Skyrizi (150 MG Dose) and Von Willebrand Factor
Determining the interaction of Skyrizi (150 MG Dose) and Von Willebrand Factor and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Skyrizi, Skyrizi topical
Generic Name: antihemophilic factor / von willebrand factor
Brand name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate
Synonyms: Antihemophilic and von Willebrand factor complex, Antihemophilic Factor/von Willebrand Factor Complex (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Skyrizi (150 MG Dose)-Von Willebrand factor recombinant
- Skyrizi (150 MG Dose)-Von willebrand factor recombinant Intravenous
- Skyrizi (150 MG Dose)-Vonvendi
- Skyrizi (150 MG Dose)-Vopac
- Skyrizi (150 MG Dose)-Vopac MDS
- Skyrizi (150 MG Dose)-Vorapaxar
- Von Willebrand Factor-Skyrizi Injection
- Von Willebrand Factor-Skyrizi topical
- Von Willebrand Factor-Sleep Aid
- Von Willebrand Factor-Sleep Aid Tablets
- Von Willebrand Factor-Sleepinal
- Von Willebrand Factor-Slo-Niacin